Health Creators – Details, episodes & analysis

Why does the current biomedical research system primarily favour Caucasian individuals?

This week I am joined by Casper Barnes, the founder and CEO of AminoChain. He's actively working on rectifying this inequality through the creation of a blockchain-based platform that enables donors to monitor their samples and earn a share of the proceeds when they are utilised for commercial purposes. This will help to incentivise participation in research from a wider range of people, and ensure that donors are fairly compensated for their contributions.

Connect with us: Neuroute - copilot for clinical trials https://www.neuroute.co/

Twitter: https://twitter.com/livialifes

LinkedIn: http://www.linkedin.com/in/livialifes G

uests: https://www.linkedin.com/in/caspar-barnes-647645155/

#CEO #Podcast #BiomedicalResearch #DiversityInResearch #BlockchainTechnology #InnovationInHealthcare #FairCompensation

What if you could control your brain through an app?

We've all heard of Neuralink and although Elon is loved by a lot of people - I'm not sure all of those people would get brain surgery to get it implanted. So yes brain-computer interfaces (BCIs) have the capability of fixing localized issues in the brain but having to go through the skull means that it's unlikely we will see the full potential of BCIs on the individual or network level unless we can make it significantly easier for people to access.

What I love about what Sumner is doing is the downstream impact of everyone having a BCI. Mood disorders are a great and impactful example of what we could solve for the individual, but what could drastically transform how society functions is the way BCIs will change how we communicate and interact with each other. Join us in this discussion on the future of BCIs, Forest Neurotech and turning sci-fi into reality.

Connect with us:

Neuroute - AI for clinical trials https://www.neuroute.co/

Twitter: https://twitter.com/livialifes

LinkedIn: http://www.linkedin.com/in/livialifes

Guests: https://www.linkedin.com/in/sumnernorman/

#CEO #Podcast #BrainTech #NeuroInnovation #MentalHealthTech

The majority of seniors find it challenging to keep up with the rapid pace of technological advancement, making it unreasonable to expect them to manage their healthcare through apps and portals.

This week, I am joined by Alex Harb (Founder/ CEO of Lena Health) dedicated to enhancing the quality of life for seniors by streamlining healthcare accessibility through technology. Lena Health offers seniors virtual personal assistants via SMS chat to efficiently manage their healthcare tasks.

Connect with us: Neuroute - copilot for clinical trials https://www.neuroute.co/

Twitter: https://twitter.com/livialifes

LinkedIn: http://www.linkedin.com/in/livialifes

Guests: https://www.linkedin.com/in/alejandroharb/

Approximately 2.2 billion people worldwide suffer from vision impairment or blindness, and out of these, at least 1 billion have vision problems that could have been prevented or have yet to be addressed. Among these cases, the primary culprits for global vision impairment and blindness are refractive errors and cataracts. (WHO, 2023)

I am joined on this week’s episode with Shivang Dave, CEO and Founder of PlenOptika. Their mission is to advance eye health by innovating optical technology, addressing the bottleneck in vision care through fast and accurate refraction at scale. We discuss the challenges of being a founder in health tech, including the time it takes to develop products, the importance of clinical validation, and the impact of their device in addressing vision problems for millions of people.

Connect with us: Neuroute - copilot for clinical trials https://www.neuroute.co/

Twitter: https://twitter.com/livialifes

LinkedIn: http://www.linkedin.com/in/livialifes

Guests: https://www.linkedin.com/in/srdave/

An estimated 35-40 million individuals are in need of prosthetic devices to replace amputated limbs. (WHO, 2017) Despite the growing demand in this market, the typical time it takes for these patients to receive a custom prosthetic can be anywhere from 8 - 20 weeks (NCBI - 2020).

Join us on this weeks episode of Health creators where I am joined by Steve Cook Founder and CEO of Taika3D. Steve's mission is to enhance the lives of millions by enhancing the efficiency and consistency of manufacturing intricate prosthetic devices through the utilisation of 3D printing technology.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547875/ https://apps.who.int/iris/bitstream/handle/10665/259209/9789241512480-part1-eng.pdf

Connect with us: Neuroute - copilot for clinical trials https://www.neuroute.co/

Twitter: https://twitter.com/livialifes

LinkedIn: http://www.linkedin.com/in/livialifes

Guests: https://www.linkedin.com/in/steve-cook-uk/

Most founders never reach product market fit. For heatlhcare founders, this challenge is more complex - building in a slow-moving landscape with complex stakeholders.

In this week's episode, Peter Kecskemethy (Founder/CEO of Kheiron Medical), Rohit Rustagi, (Founder/COO of Alfie) and I define product market fit in Healthcare as well as how to reach it.

Connect with us: Neuroute - copilot for clinical trials https://www.neuroute.co/

Twitter: https://twitter.com/livialifes

LinkedIn: http://www.linkedin.com/in/livialifes

Guests:

https://www.linkedin.com/in/kecsky/

https://www.linkedin.com/in/roru/

Mental health disorders including anxiety and depression impact 1 in 8 adults globally (WHO-2022). Despite the wide-scale impact, at present, it is estimated that patients wait more than 3 months before receiving a treatment (rcpsych-2022).

Niklas is on a mission to help patients get better therapy results and experiences by using a smart interview tool, enabling them to provide their psychiatrists with a comprehensive psychological profile. In this episode, we discuss conversational AI and where AI and psychology meet.

Connect with us: Neuroute - copilot for clinical trials https://www.neuroute.co/

Twitter: https://twitter.com/livialifes

LinkedIn: http://www.linkedin.com/in/livialifes

Guest: https://www.linkedin.com/in/niklas-no...

Reference https://www.who.int/news-room/fact-sh...

#CEO #Podcast #aiinhealthcare

Do you need to have a science background to build a science company?

In this week’s episode, Dr. Neel Patel (CEO/Founder at Zio Health), Nicole Lai (Healthcare VC) and I discuss the intricacies of building a life science startup, as well as the advantages and disadvantages of being a science entrepreneur.

Connect with us: Neuroute - copilot for clinical trials https://www.neuroute.co/

Twitter: https://twitter.com/livialifes

LinkedIn: http://www.linkedin.com/in/livialifes

Guests: Dr. Neel Patel - https://www.linkedin.com/in/neelpatel1214/

Nicole Lai - https://uk.linkedin.com/in/nicole-lai-60982070

#CEO #Podcast #ClinicalResearch #MedTech #Healthcare #Entrepreneurship

Typically, 67% of cancer patients live for 5 or more years after diagnosis (Cancer.Net, 2021). During these years, it is common for their white blood cell count (WBC) to be lower due to the cancer and/ or medication they are being treated with. This can lead to lower quality of life as they are at higher risk of infection. (Mayo Clinic, 2022) In cancer treatment, infections come second as a major cause of death. About 60% of deaths among cancer patients are connected to infections. (American Society of Clinical Oncology, 2019)

Carlos Castro Gonzales, founder of Leuko, is on a mission to improve the quality of life and outcomes for chemotherapy patients, through a light-based medical technology that counts white blood cells. In this episode, we talk about his journey building Leuko.

Connect with us:

Neuroute - copilot for clinical trials https://www.neuroute.co/

Twitter: https://twitter.com/livialifes

LinkedIn: http://www.linkedin.com/in/livialifes

Guest: https://www.linkedin.com/in/carlos-castro-gonzalez/

References: www.cancer.org/treatment/treatments-and-side-effects/physical-side-effects/infections/infections-in-people-with-cancer.html

#CancerInnovation #MedicalTechnology #NeutropeniaCare #WhiteCellMonitoring #ceo

Did you know that nearly two-thirds of patients are dissatisfied with their healthcare experiences? Even more concerning is the fact that 34% of these individuals admit to feeling inadequately informed about their personal health conditions (Heath/ PEH, 2021) This is an issue that warrants immediate attention. Back in 2017, the World Health Organisation underlined the significance of refining communication strategies across all stakeholders within the healthcare community (WHO,2017). In this week's episode of Health Creators, we are joined by esteemed guests: Pierre, co-founder of HelloBetter; Mona, co-founder of medudoc; and Lucas, the founder of Alivio. Together, they talk about their journeys of establishing very successful startups, where creating effective patient communication is key. Connect with us: Neuroute - copilot for clinical trials https://www.neuroute.co/ Twitter: https://twitter.com/livialifes LinkedIn: http://www.linkedin.com/in/livialifes Guests: Pierre Alexis Cantegril - https://www.linkedin.com/in/pacantegril/?originalSubdomain=de Mona Ciotta - https://www.linkedin.com/in/monaciotta/?originalSubdomain=de Lucas Paes de Melo - https://www.linkedin.com/in/lucas-paes-de-melo-38a8b989/?originalSubdomain=de #CEO #Podcast #ClinicalResearch #HealthTechSolutions #PatientEducation #InnovativeHealthcare